Review: taking Coumadin and Colcrys together


Summary

Drug interactions are reported among people who take Coumadin and Colcrys together. This review analyzes the effectiveness and drug interactions between Coumadin and Colcrys. It is created by eHealthMe based on reports of 26 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Colcrys >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 73,237 users)

Colcrys

Colcrys has active ingredients of colchicine. It is often used in gout. (latest outcomes from Colcrys 555 users)

On Jul, 29, 2016

26 people who take Coumadin, Colcrys are studied.


Number of reports submitted per year:

Coumadin and Colcrys drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Colcrys:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (2 of 2 people)
Colcrys:
  • female: 0.0% - (0 of 0 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Colcrys:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • drug ineffective
  • dyspnoea
  • gait disturbance
  • abdominal pain
  • agitation
  • anaemia
  • aspartate aminotransferase increased
  • asthenia
  • back pain
  • blood glucose increased
1 - 6 months:
  • pain in extremity
  • arthralgia
  • aspartate aminotransferase increased
  • blood glucose increased
  • blood triglycerides increased
  • drug ineffective
  • gout
  • hdl/cholesterol ratio decreased
  • musculoskeletal stiffness
6 - 12 months:
  • disorientation
  • poor quality sleep
not specified:
  • diarrhoea
  • weight decreased
  • back pain
  • decreased appetite
  • gout
  • bronchitis
  • dyspnoea
  • international normalised ratio increased
  • malaise
  • musculoskeletal stiffness

Most common drug interactions by gender *:

female:
  • diarrhoea
  • back pain
  • bronchitis
  • decreased appetite
  • nephrolithiasis
  • pain
  • renal pain
  • weight decreased
  • muscular weakness
  • rash generalised
male:
  • gout
  • drug ineffective
  • musculoskeletal stiffness
  • aspartate aminotransferase increased
  • dyspnoea
  • gait disturbance
  • joint stiffness
  • myalgia
  • tremor
  • weight decreased

Most common drug interactions by age *:

40-49:
  • cough
  • diarrhoea
  • dyspnoea
50-59:
  • aspartate aminotransferase increased
  • alanine aminotransferase increased
  • blood cholesterol increased
  • blood glucose increased
  • blood pressure increased
  • blood triglycerides increased
  • diverticulitis
  • dizziness
  • gout
  • hdl/cholesterol ratio decreased
60+:
  • diarrhoea
  • drug ineffective
  • dyspnoea
  • gait disturbance
  • gout
  • malaise
  • weight decreased
  • arthralgia
  • muscular weakness
  • musculoskeletal stiffness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Colcrys?

Can you answer these questions?

More questions for: Coumadin, Colcrys

You may be interested in these reviews

More reviews for: Coumadin, Colcrys

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Colcrys (colchicine) is often used to treat gout. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.